Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
We combine clinical and experimental data through machine learning techniques to explore human disease biology and promote the development of precision medicine. Our innovative Contingent AI™ technology comprehends the intricate relationships present in the data, yielding advanced insights. To combat data bias, we refine our machine learning models based on decisions made during the pre-processing and feature engineering phases. We utilize zebrafish, cellular, and various phenotypic animal models to test and confirm in silico predictions through in vivo experiments, along with genetic modifications conducted both in vitro and in vivo to enhance translation. By employing active learning and computer vision on validated models that focus on cardiac, central nervous system, and rare disorders, we swiftly integrate new data into our machine learning frameworks, allowing for continuous improvement and adaptation in our methodologies. This iterative process not only enhances the accuracy of our predictions but also enables us to stay at the forefront of research in precision medicine.
Description
The Suite is designed to be both secure and scalable, featuring a contemporary and user-friendly interface that empowers scientists to have full control over the configuration of workflows for various techniques, modalities, and data types. The latest iteration, Signals VitroVivo 3.0, formerly known as Signal’s Screening, effectively converts raw data into practical insights, while Signals Inventa 3.0, previously called Signals Lead Discovery, serves as advanced analytics software that allows researchers to publish results effortlessly from diverse data sources. Additionally, it facilitates the capture of experimental data, oversees materials management, and streamlines collaboration workflows within an easy-to-navigate cloud-based electronic notebook. With adaptable visualizations and the ability to automate instrument data processing, the Suite enhances data quality and ensures reproducibility in research. It also provides a unified data management system for scientific outcomes, enriched with dynamic, interactive analytics. Furthermore, its extensibility allows for seamless integration with internal systems and partner processes, making it an invaluable tool for scientific discovery and innovation.
API Access
Has API
No
API Access
Has API
No
Integrations
Signals Inventa
No
Signals Notebook
No
Signals Translational
No
Signals VitroVivo
No
Integrations
Signals Inventa
Yes
Signals Notebook
Yes
Signals Translational
Yes
Signals VitroVivo
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
BioSymetrics
Country
United States
Website
www.biosymetrics.com/platform
Vendor Details
Company Name
PerkinElmer Informatics
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/research/signals-research-suite/
Product Features
Product Features
Scientific Data Management System (SDMS)
Analytics
No
Artificial Intelligence (AI)
No
Audit
No
Centralized Data Repository
No
Collaboration
No
Compliance
No
Data Security
No
ELN Integration
No
LIMS Integration
No
Workflows
No